An experimental drug for metastatic pancreatic cancer nearly doubled overall survival in a Phase 3 clinical trial, offering new hope for patients with one of the deadliest forms of cancer. ABC News medical correspondent Dr. Darien Sutton breaks down the findings. #CancerResearch #Health #News #ABCNews